RationalePost-COVID19 survivors frequently have dyspnea that can lead to exercise intolerance and lower quality of life. Despite recent advances, the pathophysiological mechanisms of exercise intolerance in the post-COVID19 patients remain incompletely characterized.ObjectivesTo clarify the mechanisms of exercise intolerance in post-COVID19 survivors after hospitalization.MethodsProspective study evaluated consecutive patients previously hospitalized due to moderate-to-severe/critical COVID19. Within 90±10 days (mean±sd) of COVID19 acute symptoms onset, patients underwent a comprehensive cardiopulmonary assessment, including a cardiopulmonary exercise testing with earlobe arterialized capillary blood gas analysis.Measurements and Main ResultsEighty-seven patients were evaluated, their mean±sdpeak oxygen consumption were 19.5±5.0 ml kg−1·min−1, and the tertiles were: ≤17.0, 17.1–22.2 and ≥22.3 ml kg−1·min−1. Hospitalization severity was similar among the three groups; however, at the follow-up visit, they reported a greater sensation of dyspnea, along with indices of impaired pulmonary function, and abnormal ventilatory, gas-exchange and metabolic responses during exercise compared to patients with peak oxygen consumption >17 ml kg−1·min−1. By multivariate logistic regression analysis (ROC curve analysis) adjusted for age, sex and pulmonary embolism, a peak dead space fraction of tidal volume ≥29 and a resting forced vital capacity ≤80%predicted were independent predictors of reduced peak oxygen consumption.ConclusionsExercise intolerance in the post-COVID19 survivors was related to a high dead space fraction of tidal volume at peak exercise and a decreased resting forced vital capacity, suggesting that both pulmonary microcirculation injury and ventilatory impairment could influence aerobic capacity in this patient population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.